
Description
Grifols Partnership is a CDMO focused in add-value injectable products with a large, international pharmaceutical experience in the development and manufacturing of many types of sterile drug products. Grifols Partnership offers you an integrated project management strategy, during the development and supply of products. The team involves people from all relevant areas to implement the new processes and products at the manufacturing sites.
Type of Drugs Manufactured:
Small Molecule
CDMO Services:
Drug Product Formulation (FDF)
No. of Manufacturing Facilities:
2
High Potent Products capabilities:
OEB 3
Facilities Locations:
Europe
Regulatory Approvals:
FDA (United States);EMA (Europe);ISO;GMP;Health Canada;ANVISA (Brazil)
Current Capacity:
Glass vial lines ( from 2,5mL to 50mL) with extensive free capacity
Grifols is committed to excellence in the biopharmaceutical sector, ensuring high standards and quality in all its offerings. For more information, please visit grifols.com.